Keith’s department encompasses predevelopment support, physical pharmaceutics, formulation development and process technology to support API selection, solid dosage form design and process development for technology transfer. The group has a strong interest in the evaluation and implementation of new technology, including advanced materials profiling, predictive methods for pharmaceutical development and drug delivery systems, to facilitate new products to patients.
Prior to joining Boehringer Ingelheim, Dr. Horspool worked at Pfizer (UK and US) and AstraZeneca. He has more than 20 years of experience, during which he has managed pre-formulation, formulation development and materials science.
Keith has a BSc in pharmacy, and a PhD in pharmaceutical chemistry.